Professor, Medicine, University of Miami Leonard M. Miller School of Medicine
Cardiology
Dr. Joshua M. Hare, MD
|
|
Give Review
Joshua M. Hare, MD practices Cardiology. He researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a one of the best medicals schools. Johns Hopkins University School of Medicine is ranked 3 in research and 29 in primary care medicine He has 6 awards "America's Top Doctors", "Top Doctors:South Florida", "CMS Meaningful Use Stage 1 Certification", "Elected Member", "Fellow (FACC)" and "Super Doctor". Joshua M. Hare, MD is also published. He has 100 publications published. The lastest publication: "Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- Concise Review: Review and Perspective of Cell Dosage and Routes of Administration From Preclinical and Clinical Studies of Stem Cell Therapy for Heart Disease.
- S-Nitrosylation of Sarcomeric Proteins Depresses Myofilament Ca(2+) Sensitivity in Intact Cardiomyocytes.
- Synergistic Effects of Combined Cell Therapy for Chronic Ischemic Cardiomyopathy.
- miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, Aortic smooth muscle cells, and ApoE-/- mice.
- Effect of aging on human mesenchymal stem cell therapy in ischemic Cardiomyopathy patients.
- Adult c-Kit(+) progenitor cells are necessary for maintenance and regeneration of olfactory neurons.
- Hypotonic swelling promotes nitric oxide release in cardiac ventricular myocytes: impact on swelling-induced negative inotropic effect.
- Rationale and Design of the Percutaneous Stem Cell Injection Delivery Effects on Neomyogenesis in Dilated Cardiomyopathy (The POSEIDON-DCM Study) : A phase I/II, Rando...
- NADPH oxidase-2 inhibition restores contractility and intracellular calcium handling and reduces arrhythmogenicity in dystrophic Cardiomyopathy.
- Association between serum uric acid and Atrial fibrillation: A systematic review and meta-analysis.
- Adult c-Kit (+) progenitor cells are necessary for maintenance and regeneration of olfactory neurons.
- Long-term ablation of PKA-mediated cardiac troponin I phosphorylation leads to excitation-contraction uncoupling and diastolic dysfunction in a knock-in mouse model of...
- Bone marrow mononuclear cell therapy for Acute myocardial infarction: a perspective from the cardiovascular cell therapy research network.
- Autologous Mesenchymal Stem Cells Produce Concordant Improvements in Regional Function, Tissue Perfusion, and Fibrotic Burden When Administered to Patients Undergoing ...
- Mesenchymal stem cell therapies in the treatment of musculoskeletal Diseases.
- RNA Biomarkers for Heart Failure: Is There a Correlation Between Heart and Blood Transcriptomics?
- Synthesis of new potent agonistic analogs of growth hormone-releasing hormone (GHRH) and evaluation of their endocrine and cardiac activities.
- Transendocardial Mesenchymal Stem Cells and Mononuclear Bone Marrow Cells for Ischemic Cardiomyopathy: The TAC-HFT Randomized Trial.
- Stem cell factor improves lung recovery in rats following neonatal hyperoxia-induced lung injury.
- Adult Human Nasal Mesenchymal-Like Stem Cells Restore Cochlear Spiral Ganglion Neurons After Experimental Lesion.
- Myocarditis and ARVC/D: Variants or mimics?
- Discrete effects of A57G-myosin essential light chain mutation associated with familial hypertrophic Cardiomyopathy.
- Reply: idiopathic pulmonary fibrosis: a degenerative Disease requiring a regenerative approach.
- Stem cell therapy for pediatric dilated Cardiomyopathy.
- Cell Therapy for Lung Diseases: Report from an NIH-NHLBI Workshop November 13-14, 2012.
- Phase II Clinical Research Design in Cardiology: Learning the Right Lessons Too Well: Observations and Recommendations From the Cardiovascular Cell Therapy Research Ne...
- Nitroso-redox imbalance affects cardiac structure and function.
- Hydralazine and organic nitrates restore impaired excitation-contraction coupling by reducing calcium leak associated with nitroso-redox imbalance.
- Mesenchymal Stem Cells and Idiopathic Pulmonary Fibrosis: Potential for Clinical Testing.
- Enhanced effect of combining human cardiac stem cells and bone marrow mesenchymal stem cells to reduce infarct size and to restore cardiac function after Myocardial in...
- MicroRNA-10A* and MicroRNA-21 modulate endothelial progenitor cell senescence via suppressing high-mobility group A2.
- Anchored p90 ribosomal S6 kinase 3 is required for cardiac myocyte hypertrophy.
- Comparison of allogeneic vs autologous bone marrow-derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic Cardiomyopathy: the...
- Key developments in stem cell therapy in cardiology.
- Myocardial infarction and intraMyocardial injection models in swine.
- Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive Cardiomyopathy in mice.
- Advances in cell-based therapy for peripheral vascular Disease.
- Increased potency of cardiac stem cells compared with bone marrow mesenchymal stem cells in cardiac repair.
- Activation of growth hormone releasing hormone (GHRH) receptor stimulates cardiac reverse remodeling after Myocardial infarction (MI).
- Concise review: the role of clinical trials in deciphering mechanisms of action of cardiac cell-based therapy.
- Wnt signalling: a mediator of the Heart-bone marrow axis after myocardial injury?
- Letter by taylor et Al regarding article, "hydralazine and isosorbide dinitrate in Heart failure: historical perspectives, mechanisms, and future directions".
- Bone Marrow Therapy for Myocardial Infarction.
- Meeting report for basic cardiovascular sciences 2011 scientific sessions: from concept to clinic: leading cardiovascular translational science.
- Inhibition of miR-15 Protects Against Cardiac Ischemic Injury.
- FGF23 induces left ventricular hypertrophy.
- Mesenchymal stem cells: biology, pathophysiology, translational findings, and therapeutic implications for cardiac Disease.
- Safety of serial MRI in patients with implantable cardioverter defibrillators.
- Dual Percutaneous Mechanical Circulatory Support as a Bridge to Recovery in Fulminant Myocarditis.
- Effects of combination of proliferative agents and erythropoietin on left ventricular remodeling post-Myocardial infarction.
- Pharmacologic and genetic strategies to enhance cell therapy for cardiac regeneration.
- What is the oncologic risk of stem cell treatment for heart Disease?
- Regulation of cardiovascular cellular processes by S-nitrosylation.
- Intramyocardial stem cell injection in patients with ischemic Cardiomyopathy: functional recovery and reverse remodeling.
- Transcriptomic biomarkers for the accurate diagnosis of myocarditis.
- Caloric Restriction in Leptin Deficiency Does Not Correct Myocardial Steatosis: Failure to Normalize PPAR{alpha}/PGC1{alpha} and Thermogenic Glyecrolipid/Fatty Acid Cy...
- S-glutathionylation: a redox-sensitive switch participating in nitroso-redox balance.
- Rationale and design of the Transendocardial Injection of Autologous Human Cells (bone marrow or mesenchymal) in Chronic Ischemic Left Ventricular Dysfunction and Hear...
- Cell therapy for heart Disease: to genetically modify or not, that is the question.
- Cell therapy for heart Disease: where are we in 2011?
- Effect of granulocyte-colony stimulating factor on systolic function of oncology patients.
- Dynamic Regulation of Vascular Myosin Light Chain (MYL9) with Injury and Aging.
- Mesenchymal stem cell labeling and in vitro MR characterization at 1.5 T of new SPIO contrast agent: Molday ION Rhodamine-B™.
- Bone marrow mesenchymal stem cells stimulate cardiac stem cell proliferation and differentiation.
- β2-adrenergic receptor-coupled phosphoinositide 3-kinase constrains cAMP-dependent increases in cardiac inotropy through phosphodiesterase 4 activation.
- Impaired S-nitrosylation of the ryanodine receptor caused by xanthine oxidase activity contributes to calcium leak in Heart failure.
- Cardioprotective effects of growth hormone-releasing hormone agonist after Myocardial infarction.
- Implantation of mouse embryonic stem cell-derived cardiac progenitor cells preserves function of infarcted murine Hearts.
- A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after Acute myocardial infarction.
- Cardiac nitric oxide synthase-1 localization within the cardiomyocyte is accompanied by the adaptor protein, CAPON.
- Tracking cell fate with noninvasive imaging.
- Biomarkers of oxidative stress in Heart failure.
- S-Nitrosylation of cardiac ion channels.
- Allogeneic mesenchymal stem cells restore cardiac function in chronic ischemic Cardiomyopathy via trilineage differentiating capacity.
- The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients.
- Inhibition of the SDF-1/CXCR4 axis attenuates neonatal hypoxia-induced Pulmonary hypertension.
- Characterization of peri-infarct zone heterogeneity by contrast-enhanced multidetector computed tomography: a comparison with magnetic resonance imaging.
- Endogenous S-nitrosothiols protect against Myocardial injury.
- Sex-specific impact of aldosterone receptor antagonism on ventricular remodeling and gene expression after Myocardial infarction.
- Role of xanthine oxidoreductase in cardiac nitroso-redox imbalance.
- Translational development of mesenchymal stem cell therapy for cardiovascular Diseases.
- The adult Göttingen minipig as a model for Chronic heart failure after myocardial infarction: focus on cardiovascular imaging and regenerative therapies.
- Quantitative automated assessment of Myocardial perfusion at cardiac catheterization.
- Cardiac regeneration and stem cell therapy.
- Cardiovascular genetic medicine: genomic assessment of prognosis and diagnosis in patients with Cardiomyopathy and heart failure.
- Transcriptomic biomarkers for individual risk assessment in new-onset Heart failure.
- Noninvasive differentiation of Pulmonary arterial and venous hypertension using conventional and Doppler tissue imaging echocardiography.
- Early improvement in cardiac tissue perfusion due to mesenchymal stem cells.
- Prevalence of Mitral annulus calcification in African Americans: comparison with non-Hispanic whites and Hispanics.
- Nitric oxide and cardiobiology-methods for intact Hearts and isolated myocytes.
- Deficient ryanodine receptor S-nitrosylation increases sarcoplasmic reticulum calcium leak and arrhythmogenesis in cardiomyocytes.
- The transforming growth factor-beta/Smad3 pathway: coming of age as a key participant in cardiac remodeling.
- Characterization and prognostic value of persistent hyponatremia in patients with severe Heart failure in the ESCAPE Trial.
- Inducible NO synthase dependent S-nitrosylation and activation of arginase1 contribute to age-related endothelial dysfunction.
- Extensive left atrial thrombus in a cocaine user with a bioprosthetic mitral Valve, sinus rhythm, and left ventricular dysfunction.
- Reduced neuronal nitric oxide synthase expression contributes to cardiac oxidative stress and nitroso-redox imbalance in ob/ob mice.
- Elevated uric acid levels predict allograft vasculopathy in cardiac transplant recipients.
- Effects of weight loss after bariatric surgery on epicardial fat measured using echocardiography.
- Advances in cell-based therapy for structural heart Disease.
Schools
Johns Hopkins University School of Medicine
Johns Hopkins Hospital
Brigham Womens Hospital
Procedures Preformed
- Cardiac Catheterization (incl. Coronary Angiography)
- Cardiac Imaging
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Cardiac Myocardial Perfusion Imaging
- View All
Conditions Treated
- Angina and Acute Coronary Syndrome
- Aortic Aneurysm
- Aortic Valve Disease
- Arrhythmias (incl. Atrial Fibrillation)
- View All
Doctors Specialties
- Cardiology
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:South Florida
- CMS Meaningful Use Stage 1 Certification
- Elected Member
- Fellow (FACC)
- Super Doctor
Education
-
Brigham and Women's Hospital -
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
University of Miami Hospital
Drug Facts
| NPI NUMBER | 1548209109 | |
| NPPES Provider LastName | HARE | |
| NPPES Provider FirstName | JOSHUA | |
| NPPES Provider ZIPCode | 331361003 | |
| NPPES Provider State | FL | |
| Specialty Description | Cardiology | |
| Total Claim Count | 83.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1548209109 |
| Last Name Of The Provider | HARE |
| First Name Of The Provider | JOSHUA |
| View All |
Similar Doctors
|
|
Dr. Donald G. Rosenberg, MD
 This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael D. Dyal, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Bernardo Lopez Sanabria, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jonathan S. Roberts, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Robert C. Hendel, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Jaime P. Llobet, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Theodore Feldman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Claudia A. Martinez Bermud, MD |
|
|
Dr. Efrain H. Gonzalez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose A. Esnard Sr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Anays Santana-Izquierdo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joseph R. Casadonte, MD |
|
|
Dr. Douglas R. Slavin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ruchi C. Patel, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard D. Miller, MD |
|
|
Rajesh U. Dhairyawan, MB BCH
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melissa J. Tracy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Donna A. Tillery, PHARMD |